MedTrace Logo

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas

NCT02522897 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-08-13

No results posted yet for this study

Summary

The purpose of this study is to determine if additional panretinal photocoagulation of ischemic areas following retinal vein occlusion (RVO) may reduce the rate of recurrence and allow longer treatment intervals in anti-Vascular Endothelial Growth Factor (VEGF) treatment following the "trea-and-extend" scheme.

Conditions

  • Central Retinal Vein Occlusion With Macular Edema

Interventions

DRUG

Ranibizumab

DEVICE

Laser

Sponsors & Collaborators

  • University Hospital, Bonn

    collaborator OTHER

  • PD. Dr. med. Armin Wolf

    lead OTHER

Principal Investigators

  • Armin Wolf, PD Dr. · Eye Clinic of the Ludwig Maximilians University of Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-01-31
Completion
2018-01-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522897 on ClinicalTrials.gov